Factsheet and Information Brochure
Factsheet
Target Market
Costs and charges
Fund rules (190 kB)
Prospectus (1181 kB)
Periodic reports
Sustainability SFDR (875 kB)
Annual review (PF) (2827 kB)
Semi-annual report (PF) (200 kB)
Marketing material
Sustainability profile
Brief fund information
Summary SFDR (171 kB)
Handelsbanken Hälsovård Tema (A10 EUR)
Legal name: Handelsbanken Hälsovård Tema (A10 EUR)
Equity Fund Registered in Sweden (UCITS)
Bid
About risk
Historical yields are not a guarantee of future returns. A fund can both increase and decrease in value and it is not guaranteed that you will recover the entire invested amount. Note that a fund with risk level 5-7, as stated in the fund's fact sheet (KID), can vary greatly in value due to the fund's composition and management methodology. The prospectus, fund rules and KID are available under each fund. Summary of investors' rights.
Objectives and Investment Policy
The fund is actively managed, which means that the portfolio manager takes active, independent investment decisions. The long term objective of the fund is to exceed the returns of the underlying market, defined as the benchmark index.
Fund returns are determined by how the fund's investments in equities increase or decrease in value. The fund is a global equity fund with the objective of making investments in companies with products or services that contribute to the attainment of the Sustainable Development Goals (as defined in Agenda 2030) in general and, in particular, towards the fulfillment of Goal 3: Good health and well-being.
The fund’s objective will be attained through investments in companies within the healthcare sector. The healthcare sector refers to pharmaceuticals, medical technology, biotech, service and other healthcare-related sectors such as healthcare-related IT, aesthetics, or preventive care.
The thematic investment strategy provides for investments that occur in a limited area in which development is deemed to result in a structural change to the economy and society. This change provides favorable conditions for companies active within the area to create profitable growth over time. Our main themes are Demographics, Productivity, Lifestyles and the Environment.
International norms and guidelines for the environment, social responsibility and corporate governance are taken into consideration within the scope of the fund’s investment focus. The fund applies an exclusion strategy for companies operating within the fossil fuels, military equipment, tobacco, cannabis, alcohol, commercial gambling and pornography segments/sectors. However, the fund may invest in companies or funds that invest in companies involved in power generation, distribution or services related to fossil fuels in those cases where the company is deemed to be transitioning its operations to more renewable energy.
The fund may invest in derivative instruments as part of its investment focus. The fund may invest a maximum of 10% of the fund capital in fund units.
We compare the fund's performance with Solactive ISS ESG DM Health Care UCITS Index NTR. As the fund is actively managed the performance will over time deviate from this index.
The shareclass does not distribute dividends. All income is reinvested in the fund. Normally, you may purchase and sell fund units every banking day.
Additional information about the sustainability work, the share class designation in parentheses and the management in relation to the funds benchmark index and risk level, may be found in the prospectus.
Recommendation: This fund may not be suitable for investors who plan to withdraw their money within 5 years.
Performance
In percent including distribution
The bar chart above shows the fund’s historical performance in EUR, net of fees. If the fund pays dividends, performance is calculated with the distribution added back. Inflation has not been taken into account.
| Performance | Fund 1 | Index 2 |
|---|---|---|
| 31.10.2024 | 14.17 | 10.55 |
| 2023 | 3.32 | 0.27 |
| 2022 | 1.52 | 1.83 |
| 2021 | 21.77 | 30.03 |
| 2020 | 16.62 | 2.58 |
| Average. perf. | Fund 1 | Index 2 | 2 years | 6.76 | 3.66 |
|---|---|---|
| 3 years | 7.14 | 6.06 |
| 5 years | 13.33 | 10.08 |
| 10 years | - | - |
Sector Breakdown 31.10.2024
Largest holdings 31.10.2024
| Eli Lilly and Co | 9.35% |
| UnitedHealth Group Inc | 8.08% |
| Novo Nordisk AS Class B | 7.36% |
| Merck & Co Inc | 4.88% |
| Thermo Fisher Scientific Inc | 4.55% |
| AbbVie Inc | 4.08% |
| AstraZeneca PLC | 3.86% |
| Johnson & Johnson | 3.82% |
| Boston Scientific Corp | 3.48% |
| Amgen Inc | 3.20% |
Style Box™ 31.10.2024
Risk measures (3 years) 31.10.2024
| Total risk | 12.01% |
| Total risk in index | 11.16%* |
| Tracking error | 3.05%* |
| Information ratio | 0.35* |
| Sharpe ratio | 0.40 |
| Sharpe ratio index | 0.34* |
Distributions are reinvested in the funds and their benchmarks to obtain relevant comparisons. All key figures are calculated on the basis of effective annual yields. Values for the past three years have been used for the majority of funds. For newer funds Handelsbanken Fonder AB uses Bloomberg Port for risk forecast calculations.
Total risk/Total risk in index is stated as the standard deviation for variations in the fund/index's monthly yields. The higher the number, the higher the risk.
Tracking error is measured as the standard deviation for the difference between yields in the fund and its benchmark (variation in relative yields). The historical tracking error indicates how much the fund’s yield has deviated from its benchmark.
Information ratio is a measure of the active returns attained by the fund by deviating from its benchmark. It is the ratio between the active returns and the tracking error. A negative information ratio means that the fund has underperformed its benchmark.
Sharpe ratio/Sharpe ratio is a measure of the fund/index’s return, taking into account the risk of the fund/index. A high return attained at a lower risk is better than an equivalent return attained at a high risk. Calculated, on the one hand, as the ratio between the return, less the risk-free interest (interest on government securities) and, on the other hand, the total risk of the fund/index. The Sharpe ratio is most relevant to compare the yields of various markets, while taking risk into account.
Total risk/Total risk in index is stated as the standard deviation for variations in the fund/index's monthly yields. The higher the number, the higher the risk.
Tracking error is measured as the standard deviation for the difference between yields in the fund and its benchmark (variation in relative yields). The historical tracking error indicates how much the fund’s yield has deviated from its benchmark.
Information ratio is a measure of the active returns attained by the fund by deviating from its benchmark. It is the ratio between the active returns and the tracking error. A negative information ratio means that the fund has underperformed its benchmark.
Sharpe ratio/Sharpe ratio is a measure of the fund/index’s return, taking into account the risk of the fund/index. A high return attained at a lower risk is better than an equivalent return attained at a high risk. Calculated, on the one hand, as the ratio between the return, less the risk-free interest (interest on government securities) and, on the other hand, the total risk of the fund/index. The Sharpe ratio is most relevant to compare the yields of various markets, while taking risk into account.
Facts
| Fund Facts | |
|---|---|
| Fund managed by | Christopher Sundman |
| Country of registration | Sweden |
| Main category | Equity Fund |
| Sub category | Global |
| Fund, date of launch | 01.12.2000 |
| Share class, date of launch | 21.10.2020 |
| Fund assets | 22,470 MSEK (31.05.2024) |
| Reporting Currency | EUR |
| Trading Currency | - |
| Instrument category | Uncomplicated |
| UCITS | Yes |
| ISIN | SE0012741171 |
| Short name | HTA10E |
| Available for sale | Finland, Sweden |
| Fund Company Facts | |
|---|---|
| Management Company | Handelsbanken Fonder AB |
| Approval of fund operations | 06.05.1991 |
| Other approvals |
Discretionary Asset Management Manager of Alternative Investment Funds (AIFs) Provide investment advice Receive and forward orders
|
| Custodian Institution | J. P. Morgan SE - Stockholm Bankfilial |
| Legal domicile of fund | Stockholm, Sweden |
| Regulation Authority | Swedish Financial Supervisory Authority |
| Auditor | PricewaterhouseCoopers |
| Complaints Manager | Jörgen Larson |